Home LiteratureArticle Details
PMID: 14578350 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Role of p38alpha Map kinase in Type I interferon signaling.

The Journal of biological chemistry ·Vol. 279 ·No. 2 ·2004-01-09 ·Pages 970-9

Li Y, Sassano A, Majchrzak B, Deb DK, Levy DE, Gaestel M, Nebreda AR, Fish EN, Platanias LC

Abstract

Multiple signaling pathways are activated during engagement of the Type I interferon (IFN) receptor to mediate biological responses, including the Jak-Stat and Rac1/p38 Map kinase signaling cascades. In the present study we sought to determine the functional relevance of the p38alpha isoform in IFN signaling, using cells from mouse embryos with targeted disruption of the p38alpha gene. Our data demonstrate that p38alpha activation is essential for Type I IFN-dependent transcriptional regulation via ISRE or GAS elements. On the other hand, the function of p38alpha is not required for IFN-dependent Ser727 or Tyr701 phosphorylation of Stat1 and does not impact on the formation of ISGF3 or SIF nuclear binding complexes. In efforts to identify downstream effectors of p38 that may mediate IFN-dependent transcriptional responses, we found that IFNalpha activates the kinase Msk1, a known regulator of histone phosphorylation and chromatin remodeling. In other studies, we demonstrate that Type I IFN-dependent activation of the kinases MapKapK-2 and MapKapK-3 is defective in the absence of p38alpha, while Type I IFN-dependent antiviral properties are decreased in cells with targeted disruption of the MapKapK-2 gene. Altogether, our data establish that the p38alpha Map kinase pathway regulates activation of downstream effectors that participate in the induction of IFN-dependent gene transcription, to mediate IFN-responses.

MeSH Terms
Animals Cell Line, Tumor Chromatin/metabolism Dose-Response Relationship, Drug Electrophoresis, Polyacrylamide Gel Fibroblasts/metabolism Humans Immunoblotting Interferon Type I/metabolism Interferon-gamma/metabolism Intracellular Signaling Peptides and Proteins Luciferases/metabolism Mice Mitogen-Activated Protein Kinase 14 Mitogen-Activated Protein Kinases/metabolism,physiology Osmosis Phosphorylation Protein Binding Protein Serine-Threonine Kinases/metabolism Recombinant Proteins/metabolism Serine/chemistry Signal Transduction Stress, Physiological Time Factors Transcription, Genetic Transfection Tyrosine/chemistry
Chemicals
Chromatin Interferon Type I Intracellular Signaling Peptides and Proteins Recombinant Proteins Tyrosine Serine Interferon-gamma Luciferases MAP-kinase-activated kinase 2 MAP-kinase-activated kinase 3 Protein Serine-Threonine Kinases Mitogen-Activated Protein Kinase 14 Mitogen-Activated Protein Kinases
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Li Yongzhong
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School and Lakeside Veterans Administration Medical Center, Chicago, Illinois 60611, USA.
Sassano Antonella
Majchrzak Beata
Deb Dilip K
Levy David E
Gaestel Matthias
Nebreda Angel R
Fish Eleanor N
Platanias Leonidas C
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2004-01-09
Epub
2003-00-24
Pages
970-9
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NCI NIH HHS · CA77816 · United States
NCI NIH HHS · CA94079 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com